How AI is changing hospitals, drug discovery, and patient care — weekly highlights.
This week in healthcare AI: the FDA's evolving "breakthrough" device designation strategy comes under scrutiny, DIAGNOS renews its FDA registration, and a fresh wave of funding signals continued investor confidence in clinical AI infrastructure. Trust barriers and evidence gaps remain a persistent theme across clinical deployment discussions.
This week saw the FDA clear a new Philips AI system for real-time cardiac guidance, state-level AI regulation continued to fill federal gaps, and two major funding rounds totaled over $165 million for AI health infrastructure. Oncology AI deployments and a novel patient-facing GPT tool also made headlines.
This week in AI healthcare: new peer-reviewed research examines global regulatory gaps for generative AI medical devices and the emerging role of agentic AI in clinical settings; a University of Utah lab-on-a-chip platform promises same-day pediatric cancer treatment decisions; and a $1 billion raise tied to Yann LeCun's new venture has direct implications for health AI documentation. Regulators and clinicians alike are navigating a rapidly accelerating landscape.
This week in AI healthcare: regulators wrestle with how to govern generative AI in medical devices, Ryght.ai's Simon Arkell explains how digital twins are reinventing clinical trial site selection, and a fresh Nature perspective calls for urgent reform of global regulatory frameworks for LLM-based medical tools.
Create custom signals on any topic. AI curates and delivers 24/7.
Create SignalPowered by
